Production (Stage)
Rakovina Therapeutics Inc.
RKV.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.06M | -744.70K | -599.70K | -558.10K | -531.30K |
| Total Depreciation and Amortization | 96.50K | 99.10K | 97.70K | 99.10K | 99.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 56.20K | 29.60K | 42.50K | 39.80K | 55.10K |
| Change in Net Operating Assets | -349.60K | -407.90K | 138.10K | 226.90K | 99.70K |
| Cash from Operations | -1.26M | -1.02M | -321.40K | -192.20K | -277.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.93M | 300.00K | 1.70M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -107.60K | -34.80K | -46.00K | -- | 0.00 |
| Cash from Financing | 2.01M | 194.40K | 1.21M | -- | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 755.60K | -829.50K | 883.70K | -192.20K | -277.10K |